Literature DB >> 32313246

Cxcl10+ monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation.

Amir Giladi1, Lisa Katharina Wagner2, Hanjie Li1, Dorothea Dörr2, Chiara Medaglia1, Franziska Paul1, Anat Shemer1, Steffen Jung1, Simon Yona3, Matthias Mack4, Achim Leutz2,5, Ido Amit6, Alexander Mildner7.   

Abstract

Multiple sclerosis (MS) is characterized by pathological inflammation that results from the recruitment of lymphoid and myeloid immune cells from the blood into the brain. Due to subset heterogeneity, defining the functional roles of the various cell subsets in acute and chronic stages of MS has been challenging. Here, we used index and transcriptional single-cell sorting to characterize the mononuclear phagocytes that infiltrate the central nervous system from the periphery in mice with experimentally induced autoimmune encephalomyelitis, a model of MS. We identified eight monocyte and three dendritic cell subsets at acute and chronic disease stages in which the defined transcriptional programs pointed toward distinct functions. Monocyte-specific cell ablation identified Cxcl10+ and Saa3+ monocytic subsets with a pathogenic potential. Transfer experiments with different monocyte and precursor subsets indicated that these Cxcl10+ and Saa3+ pathogenic cells were not derived from Ly6C+ monocytes but from early myeloid cell progenitors. These results suggest that blocking specific pathogenic monocytic subsets, including Cxcl10+ and Saa3+ monocytes, could be used for targeted therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32313246     DOI: 10.1038/s41590-020-0661-1

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  45 in total

Review 1.  A close encounter of the third kind: monocyte-derived cells.

Authors:  Alexander Mildner; Simon Yona; Steffen Jung
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

2.  Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool.

Authors:  Bahareh Ajami; Jami L Bennett; Charles Krieger; Kelly M McNagny; Fabio M V Rossi
Journal:  Nat Neurosci       Date:  2011-07-31       Impact factor: 24.884

3.  Granulocyte-Monocyte Progenitors and Monocyte-Dendritic Cell Progenitors Independently Produce Functionally Distinct Monocytes.

Authors:  Alberto Yáñez; Simon G Coetzee; Andre Olsson; David E Muench; Benjamin P Berman; Dennis J Hazelett; Nathan Salomonis; H Leighton Grimes; Helen S Goodridge
Journal:  Immunity       Date:  2017-11-21       Impact factor: 31.745

4.  Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells.

Authors:  Zhaoyuan Liu; Yaqi Gu; Svetoslav Chakarov; Camille Bleriot; Immanuel Kwok; Xin Chen; Amanda Shin; Weijie Huang; Regine J Dress; Charles-Antoine Dutertre; Andreas Schlitzer; Jinmiao Chen; Lai Guan Ng; Honglin Wang; Zhiduo Liu; Bing Su; Florent Ginhoux
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

5.  Genomic Characterization of Murine Monocytes Reveals C/EBPβ Transcription Factor Dependence of Ly6C- Cells.

Authors:  Alexander Mildner; Jörg Schönheit; Amir Giladi; Eyal David; David Lara-Astiaso; Erika Lorenzo-Vivas; Franziska Paul; Louise Chappell-Maor; Josef Priller; Achim Leutz; Ido Amit; Steffen Jung
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

6.  CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system.

Authors:  Alexander Mildner; Matthias Mack; Hauke Schmidt; Wolfgang Brück; Marija Djukic; Mark D Zabel; Andrea Hille; Josef Priller; Marco Prinz
Journal:  Brain       Date:  2009-06-16       Impact factor: 13.501

7.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

8.  Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease.

Authors:  Irah L King; Travis L Dickendesher; Benjamin M Segal
Journal:  Blood       Date:  2009-02-05       Impact factor: 22.113

9.  The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells.

Authors:  Shinelle Menezes; Daisy Melandri; Giorgio Anselmi; Thibaut Perchet; Jakob Loschko; Juan Dubrot; Rajen Patel; Emmanuel L Gautier; Stéphanie Hugues; M Paula Longhi; Jake Y Henry; Sergio A Quezada; Grégoire Lauvau; Ana-Maria Lennon-Duménil; Enrique Gutiérrez-Martínez; Alain Bessis; Elisa Gomez-Perdiguero; Christian E Jacome-Galarza; Hannah Garner; Frederic Geissmann; Rachel Golub; Michel C Nussenzweig; Pierre Guermonprez
Journal:  Immunity       Date:  2016-12-20       Impact factor: 31.745

10.  Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal.

Authors:  Leo M Carlin; Efstathios G Stamatiades; Cedric Auffray; Richard N Hanna; Leanne Glover; Gema Vizcay-Barrena; Catherine C Hedrick; H Terence Cook; Sandra Diebold; Frederic Geissmann
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

View more
  31 in total

Review 1.  The immunology of multiple sclerosis.

Authors:  Kathrine E Attfield; Lise Torp Jensen; Max Kaufmann; Manuel A Friese; Lars Fugger
Journal:  Nat Rev Immunol       Date:  2022-05-04       Impact factor: 53.106

Review 2.  Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.

Authors:  Alanna G Spiteri; Claire L Wishart; Roger Pamphlett; Giuseppe Locatelli; Nicholas J C King
Journal:  Acta Neuropathol       Date:  2021-12-01       Impact factor: 17.088

3.  Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma.

Authors:  Andrea Cugurra; Tornike Mamuladze; Justin Rustenhoven; Taitea Dykstra; Giorgi Beroshvili; Zev J Greenberg; Wendy Baker; Zach Papadopoulos; Antoine Drieu; Susan Blackburn; Mitsuhiro Kanamori; Simone Brioschi; Jasmin Herz; Laura G Schuettpelz; Marco Colonna; Igor Smirnov; Jonathan Kipnis
Journal:  Science       Date:  2021-06-03       Impact factor: 47.728

Review 4.  Diversity and Function of Glial Cell Types in Multiple Sclerosis.

Authors:  Lucas Schirmer; Dorothy P Schafer; Theresa Bartels; David H Rowitch; Peter A Calabresi
Journal:  Trends Immunol       Date:  2021-02-13       Impact factor: 16.687

5.  Macrophage Responses to Environmental Stimuli During Homeostasis and Disease.

Authors:  Adil Rasheed; Katey J Rayner
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

6.  Exosomes From Subjects With Multiple Sclerosis Express EBV-Derived Proteins and Activate Monocyte-Derived Macrophages.

Authors:  May F Mrad; Esber S Saba; Layane Nakib; Samia J Khoury
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-18

7.  Perinatal development of innate immune topology.

Authors:  Philipp Henneke; Katrin Kierdorf; Lindsey J Hall; Markus Sperandio; Mathias Hornef
Journal:  Elife       Date:  2021-05-25       Impact factor: 8.140

Review 8.  Macrophage reprogramming for therapy.

Authors:  Valentina M T Bart; Robert J Pickering; Philip R Taylor; Natacha Ipseiz
Journal:  Immunology       Date:  2021-01-25       Impact factor: 7.215

9.  IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells.

Authors:  Javad Rasouli; Giacomo Casella; Larissa L W Ishikawa; Rodolfo Thome; Alexandra Boehm; Adam Ertel; Carolina R Melo-Silva; Elisabeth R Mari; Patrizia Porazzi; Weifeng Zhang; Dan Xiao; Luis J Sigal; Paolo Fortina; Guang-Xian Zhang; Abdolmohamad Rostami; Bogoljub Ciric
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

10.  Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.

Authors:  Hila Ben-Yehuda; Michal Arad; Javier María Peralta Ramos; Efrat Sharon; Giulia Castellani; Shir Ferrera; Liora Cahalon; Sarah Phoebeluc Colaiuta; Tomer-Meir Salame; Michal Schwartz
Journal:  Mol Neurodegener       Date:  2021-06-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.